Abstract |
Transforming growth factor-beta type 1 ( TGF-beta) has been implicated as both a tumor suppressor and a tumor promoter in many solid epithelial cancers. We have previously demonstrated that the cyclin dependent kinase (CDK) inhibitor p21 acts as a molecular switch in determining a growth inhibitory versus growth proliferative response to TGF-beta in the spontaneously immortalized human mammary epithelial cell line MCF-10A. We now demonstrate that this proliferative effect of TGF-beta is mediated through the proinflammatory cytokine, interleukin-1alpha (IL-1alpha). Using gene expression array analysis, we identified IL-1alpha as a cytokine specifically upregulated only in cells lacking p21 and only upon TGF-beta stimulation. Cell proliferation assays verified that recombinant IL-1alpha was capable of inducing a growth proliferative response in p21 null MCF-10A cells, while neutralizing antibodies against IL-1alpha prevented the growth proliferative effects of TGF-beta. Mechanistically, both the CDK and proliferating cell nuclear antigen ( PCNA) inhibitory functions of p21 were responsible for preventing TGF-beta induced cell proliferation, but only PCNA inhibition by p21 regulated IL-1alpha gene expression. These studies demonstrate a novel role for IL-1alpha in mediating a proliferative response to TGF-beta signaling, and suggest that therapies directed against IL-1alpha could abate the growth proliferative effects of TGF-beta without compromising its tumor suppressive function.
|
Authors | B Karakas, A Weeraratna, A Abukhdeir, B G Blair, H Konishi, S Arena, K Becker, W Wood 3rd, P Argani, A M De Marzo, K E Bachman, B H Park |
Journal | Oncogene
(Oncogene)
Vol. 25
Issue 40
Pg. 5561-9
(Sep 07 2006)
ISSN: 0950-9232 [Print] England |
PMID | 16619041
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- CDKN1A protein, human
- Cyclin-Dependent Kinase Inhibitor p21
- Interleukin-1
- Nucleic Acid Synthesis Inhibitors
- Proliferating Cell Nuclear Antigen
- Transforming Growth Factor beta
- Dactinomycin
|
Topics |
- Cell Line, Tumor
- Cell Proliferation
- Cyclin-Dependent Kinase Inhibitor p21
(genetics, metabolism)
- Dactinomycin
(pharmacology)
- Humans
- Interleukin-1
(genetics, metabolism)
- Nucleic Acid Synthesis Inhibitors
(pharmacology)
- Oligonucleotide Array Sequence Analysis
- Proliferating Cell Nuclear Antigen
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- Second Messenger Systems
- Signal Transduction
- Transforming Growth Factor beta
(metabolism)
- Up-Regulation
|